Literature DB >> 26081087

[A mouse model for acute otitis media via transbullar injection].

Yifei Huang1, Chunfang Jin1, Yun Xiang1, Lei Wang1, Zimeng Wang1, Wei Wang1, Yujuan He2.   

Abstract

OBJECTIVE: To develop a mouse model for acute otitis media (AOM) via transbullar injection method and evaluate its feasibility and practicability.
METHODS: The middle ears (ME) of C57BL/6 mice were inoculated via transbullar injection method with 5 µl streptococcus pneumoniae (S.pn) 19F suspension (1×10(7) CFU/ml), and the control group was inoculated equivalent phosphate buffered solution (PBS). Behavior changes were observed daily following inoculation. The ME tissues for histological examination and the middle ear lavage fluid (MELF) for total cells quantification, S.pn load determination and cytokines measurement were collected at 12 h, day 1, 2, 3, 5, 7 after inoculation, respectively.
RESULTS: Within 24 hours after instillation, the density of S.pn and the level of acute inflammatory cytokines in ME cavity increased rapidly, some mucosal hyperplasia was evident and leukocytic infiltration (primarily neutrophils) began. The level of ME inflammatory response reached maximal at 2-3 days after inoculation, with extensive effusion, leukocytic infiltration and mucosal thickening. Meanwhile, the density of S.pn decreased gradually. Bacterial clearance was completed by day 5 with extensive resolution of ME inflammation, although mucosal hyperplasia did not resolute until day 7.
CONCLUSION: A mouse model for AOM is successfully established via transbullar injection method, laying foundation for future study of AOM.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26081087

Source DB:  PubMed          Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1673-0860


  1 in total

1.  TLR2 promotes macrophage recruitment and Streptococcus pneumoniae clearance during mouse otitis media.

Authors:  Yifei Huang; Zimeng Wang; Chunfang Jin; Lei Wang; Xuemei Zhang; Wenchun Xu; Yun Xiang; Wei Wang; Xiujing He; Yibing Yin; Yujuan He
Journal:  Pediatr Res       Date:  2016-07-27       Impact factor: 3.756

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.